antimicrobial peptides regulated by il-17 Update and Review,17A

The intricate interplay between the immune system and invading pathogens relies heavily on a sophisticated network of molecular signals. Among these, Interleukin-17 (IL-17), a pro-inflammatory cytokine primarily produced by Th17 cells, has emerged as a pivotal regulator of host defense mechanisms, particularly through its influence on the production and function of antimicrobial peptides (AMPs). This article delves into the multifaceted ways IL-17 orchestrates the expression of antimicrobial peptides, highlighting their significance in combating infections and maintaining tissue homeostasis.

Research has unequivocally demonstrated that IL-17 cytokines are critical for the upregulation of various antimicrobial peptides. Studies have shown that IL-17A is required for the increased expression of antimicrobial peptides like CRAMP, mBD-3, and mBD-14 during challenges such as *Staphylococcus aureus* nasal colonization. This direct regulatory role underscores IL-17's importance in initiating a rapid and localized antimicrobial response. Furthermore, findings indicate that IL-17 directly regulates Paneth cell antimicrobial functions, suggesting a broad impact across different cell types involved in innate immunity.

The mechanism by which IL-17 exerts its influence involves its interaction with specific receptors. The IL17 receptor complex, which includes IL17RA, plays a pivotal role in IL17A-mediated signaling. This signaling cascade drives robust pro-inflammatory responses and the recruitment of immune cells to sites of infection. Importantly, IL17RA is ubiquitously expressed on a wide range of tissues and cell types, enabling IL-17 to exert its regulatory effects broadly.

Beyond IL-17A, other IL-17 family members, such as IL-17F, also contribute to this defense pathway. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells, and their synergistic action cooperatively enhances the expression of antimicrobial peptides. This cooperative enhancement is crucial for mounting an effective defense, particularly against fungal infections like *Candida albicans*. Indeed, IL-17 signaling appears to mediate mucosal immunity against C. albicans by regulating the expression of AMPs in the oral mucosa.

The spectrum of antimicrobial peptides influenced by IL-17 is diverse. These peptides, also known as host defence peptides, are immunomodulatory molecules required to resolve infections. They possess a broad range of antimicrobial activities and can modulate the host's immune response. For instance, the neutrophil antimicrobial peptide cathelicidin promotes Th17 differentiation, creating a feedback loop that further amplifies the IL-17-mediated response. Cathelicidins themselves display broad-spectrum antimicrobial activity and can neutralize endotoxins.

The regulation of antimicrobial peptides by IL-17 is not a singular event but rather a dynamic process. Th17 cytokines IL-17A and IL-22 differentially affect antimicrobial peptide expression, highlighting the nuanced control exerted by these signaling molecules. IL-17 acts on fibroblasts, immune cells, and epithelial cells, inducing the production of not only antimicrobial molecules but also other crucial immune mediators like cytokines and chemokines.

Emerging therapeutic strategies are also targeting the IL-17 pathway. Modulating IL-17 levels has shown potential in mitigating disease symptoms, positioning it as a compelling target for drug development. Innovative peptide therapeutics are being designed to inhibit the IL17A-IL17RA signaling pathway, with specific examples like AL-8(0), a novel peptide designed for this purpose. Furthermore, research is exploring peptide inhibitors that can disrupt interactions within the IL-17RB pathway, such as the development of a cyclic peptide that disrupts the IL-17RB–MLK4 interaction. Efforts are also underway to develop oral peptide inhibitors designed to target not only IL-17A/A and IL-17A/F but also other IL-17 family members.

In summary, IL-17 plays a central and indispensable role in the host's defense against microbial threats. Its ability to directly and indirectly regulate the expression and function of a diverse array of antimicrobial peptides makes it a critical component of innate and adaptive immunity. Understanding this complex regulation is crucial for developing effective strategies to combat infections and manage inflammatory diseases. The continuous research into IL-17 and its downstream effectors, including antimicrobial peptides, promises further advancements in our ability to harness these natural defense mechanisms for therapeutic benefit.